Biomarkers in Migraine
| Autor: | E M Gibson Depoy, Ayesha Ahmad, Stephanie J. Nahas, Brian M Yan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
business.industry
Cerebral Spinal Fluid Calcitonin Gene-Related Peptide Migraine Disorders Headache Calcitonin gene-related peptide Gene mutation Bioinformatics Precision medicine medicine.disease Clinical Practice Neurology Migraine Medicine Biomarker (medicine) Humans Pituitary Adenylate Cyclase-Activating Polypeptide Clinical significance Neurology (clinical) business Biomarkers |
| Zdroj: | Neurology India. 69 |
| ISSN: | 1998-4022 |
| Popis: | Background: Disability from migraine has a profound impact on the world's economy. Research has been ongoing to identify biomarkers to aid in diagnosis and treatment. Objective: The aim of this study was to highlight the purported diagnostic and therapeutic migraine biomarkers and their role in precision medicine. Methods: A comprehensive literature search was conducted using PubMed, Google Scholar, and clinicaltrials.gov using keywords: “migraine” OR “headache” combined with “biomarkers” OR “marker.” Other keywords included “serum,” “cerebral spinal fluid,” “inflammatory,” and “neuroimaging.” Results: After a review of 88 papers, we find the literature supports numerous biomarkers in the diagnosis of migraine. Therapeutic biomarkers, while not as extensively published, highlight calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating peptide-38 (PACAP-38) as biomarkers with the most substantiated clinical relevance. Genetic markers mainly focusing on gene mutations with resultant biochemical alterations continue to be studied and show promise. Conclusion: Although there are several proposed biomarkers for migraine, continued research is needed to substantiate their role in clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|